Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Earnings

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • Equities
  • News

Calumet’s Mixed Bag Q1: From Loss To Grit, CEO Maps Strategic Spring Surge

By Akanksha Bakshi
May 10, 9:31 AM
CLMT reports Q1 fiscal 2024 sales decline of 3%, beating consensus. Net loss per unit $(0.51) down from $0.23 YoY. Gross profit down 18.7% YoY.

CLMT

Read More
2 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

FDA Delays ‘Important’ Moderna Vaccine Review: William Blair Says 2025 Growth, ‘2026 Breakeven Story’ Depends On It

By Vandana Singh
May 10, 9:27 AM
FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

GSK

Read More
2 minute read
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results

By Avi Kapoor
May 10, 9:23 AM
Revance Therapeutics, Inc. (NASDAQ:AKAM) posted a loss for its first quarter on Thursday. Revance Therapeutics posted a GAAP…

AKAM

Read More
1 minute read
  • Earnings
  • Guidance
  • Media
  • Movers
  • News
  • Tech
  • Top Stories

AMC Networks Stock Slips: What’s Behind the Sharp Revenue and EPS Decline?

By Anusuya Lahiri
May 10, 9:05 AM
AMC Networks Inc (AMCX) reported Q1 2024 revenue decline of 16.9%, missing analyst estimates. Streaming subscribers increased but stock price fell.

AMCX

Read More
2 minute read
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

Akamai Technologies Analysts Cut Their Forecasts After Weak Forecast

By Avi Kapoor
May 10, 9:05 AM
Akamai Technologies, Inc. (NASDAQ:AKAM) posted upbeat earnings for its first quarter, but issued weak guidance. Akamai Technologies posted…

AKAM

Read More
2 minute read
  • Buybacks
  • Dividends
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Movers
  • News

Why Is Construction Materials Company CRH Stock Up Premarket Friday?

By Lekha Gupta
May 10, 9:03 AM
CRH shares rise on Q1 FY24 results, $0.4B share repurchase, $0.35 dividend, and positive outlook for 2024. Revenue up 2% to $6.5B.

CRH

Read More
2 minute read
  • Cannabis
  • Earnings
  • News

Leafly Q1 Revenue Dips Nearly 20% YoY, But Weed Discovery Marketplace Also Reduced Net Loss And Cut Costs

By Nina Zdinjak
May 10, 8:54 AM
Cannabis discovery marketplace  Leafly Holdings, Inc. (NASDAQ:LFLY) reported its financial results Thursday for its first quarter ended March 31, 2024,…

LFLY

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

These Analysts Cut Their Forecasts On Allegro MicroSystems Following Q4 Results

By Avi Kapoor
May 10, 8:43 AM
Allegro MicroSystems, Inc. (NASDAQ:ALGM) reported better-than-expected fourth-quarter financial results on Thursday. Allegro Microsystems posted adjusted earnings of 25…

ALGM

Read More
2 minute read
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results

By Avi Kapoor
May 10, 8:32 AM
ADMA Biologics, Inc. (NASDAQ:ADMA) reported better-than-expected first-quarter financial results and issued strong revenue guidance on Thursday. ADMA Biologics…

ADMA

Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Why Is Toy Maker Funko’s Stock Gaining Today?

By Shivani Kumaresan
May 10, 8:25 AM
Funko Inc marks a positive stride with Q1 adjusted EPS surpassing expectations. Despite a 14.5% sales dip, strategic inventory management leads to solid gross margin.

FNKO

Posts pagination

Previous 1 … 65 66 67 … 3,239 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service